Study guide
7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
Key Takeaways Explain This Topic AI
Absolute contraindications to exercise—such as unstable angina within 48 hours, decompensated heart failure, severe symptomatic aortic stenosis, acute pulmonary embolism, and dissecting aneurysm—mandate withholding exercise until complete medical stabilization.
In-session exercise must be terminated immediately for adverse signs and symptoms including moderate-to-severe angina (>= 2 on 1–4 scale), sustained drop in SBP > 10 mmHg with increasing workload, exertional SBP > 220–250 mmHg, CNS symptoms, or complex ventricular arrhythmias.
Supplemental oxygen is clinically indicated during acute exertional distress only when oxygen saturation (SpO2) drops below 90% to 92%, as hyperoxia in normoxemic patients causes paradoxical coronary vasoconstriction and increased oxidative stress.
Sublingual nitroglycerin (0.4 mg every 5 minutes up to 3 doses) requires a baseline SBP >= 90–100 mmHg and is strictly contraindicated within 24 hours of sildenafil/vardenafil or 48 hours of tadalafil use due to life-threatening, refractory hypotension.
In an acute chest pain emergency, staff must stop exercise, place the patient in a seated or recumbent position, record a 12-lead ECG, verify vitals, assess contraindications prior to nitroglycerin, and activate emergency medical response if symptoms fail to resolve after the first dose.
Last updated: September 2026
7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
Patient safety in cardiac rehabilitation depends on rigorous pre-exercise screening, continuous clinical monitoring, and prompt execution of emergency protocols. Because cardiac rehabilitation cohorts include individuals with advanced ischemic heart disease, heart failure, and arrhythmias, clinicians must rapidly recognize contraindications, adverse exertional responses, and acute emergencies.
Absolute vs. Relative Contraindications to Exercise
Before clearing any patient for exercise, clinical staff must evaluate baseline clinical stability:
Absolute Contraindications (Exercise Strictly Prohibited)
In the presence of an absolute contraindication, exercise testing and training must be withheld until the condition is medically evaluated and stabilized:
Unstable Angina: New-onset severe angina, resting angina, or accelerating angina within the preceding 48 hours.
Acute Decompensated Heart Failure: Resting dyspnea, orthopnea, new S3 gallop, bilateral pulmonary crackles, jugular venous distention, or rapid fluid weight gain ( > 3 to 5 lbs >3\text{ to }5\text{ lbs} > 3 to 5 lbs in 48 to 72 hours).
Uncontrolled Lethal Arrhythmias: Sustained ventricular tachycardia, rapid atrial fibrillation with uncontrolled ventricular response ( > 110 to 120 bpm >110\text{ to }120\text{ bpm} > 110 to 120 bpm at rest), or symptomatic high-grade ventricular ectopy.
Severe Symptomatic Aortic Stenosis: Mean gradient > 40 mmHg >40\text{ mmHg} > 40 mmHg or valve area < 1.0 cm 2 <1.0\text{ cm}^2 < 1.0 cm 2 with exertional angina, syncope, or dyspnea. Fixed outflow obstruction prevents cardiac output from rising, risking exertional collapse or sudden death.
Acute Pulmonary Embolism or Acute DVT: Until therapeutic anticoagulation is established ( ≥ 24 to 48 \ge 24\text{ to }48 ≥ 24 to 48 hours) and symptoms stabilize.
Acute Myocarditis or Acute Pericarditis: Active inflammation creates electrical instability, predisposing to fatal arrhythmias.
Acute Aortic Dissection: Known or suspected thoracic or abdominal dissecting aneurysm.
Acute Systemic Infection: Febrile illness or severe infection accompanied by resting tachycardia.
Relative Contraindications (Requires Medical Review & Modification)
Exercise may proceed only after physician consultation, weighing benefits against risks, with conservative workloads and continuous monitoring:
Left Main Coronary Stenosis: Severe unbypassed/unrevascularized stenosis ( ≥ 50 % \ge 50\% ≥ 50% ).
Moderate Stenotic Valvular Disease: Moderate aortic stenosis (valve area 1.0 to 1.5 cm 2 1.0\text{ to }1.5\text{ cm}^2 1.0 to 1.5 cm 2 ) or severe asymptomatic aortic stenosis.
Resting Severe Hypertension: Resting SBP > 200 mmHg >200\text{ mmHg} > 200 mmHg or resting DBP > 110 mmHg >110\text{ mmHg} > 110 mmHg . Have the patient rest quietly for 15 minutes; if blood pressure remains above these thresholds, withhold exercise and consult the physician.
High-Degree Atrioventricular Block: Mobitz Type II second-degree AV block or complete third-degree AV block without a functioning permanent pacemaker.
Hypertrophic Obstructive Cardiomyopathy (HOCM): With severe dynamic resting outflow tract gradients.
Severe Tachycardia or Bradycardia: Resting HR > 100 to 110 bpm >100\text{ to }110\text{ bpm} > 100 to 110 bpm or symptomatic bradycardia < 50 bpm <50\text{ bpm} < 50 bpm .
Uncontrolled Metabolic Disease: Severe diabetic ketoacidosis, hyperosmolar state, or blood glucose > 300 to 400 mg/dL >300\text{ to }400\text{ mg/dL} > 300 to 400 mg/dL with ketones.
Exercise Contraindications Classification Table
Classification Clinical Condition Pathophysiologic Hazard Mandatory Staff Action
Absolute Unstable Angina (<48h) Plaque rupture; imminent transmural MI Withhold exercise; transfer for emergency ACS workup
Absolute Decompensated Heart Failure Pulmonary congestion; cardiogenic shock Withhold exercise; urgent physician referral for diuresis
Absolute Severe Symptomatic Aortic Stenosis Fixed outflow obstruction; syncope/sudden death Withhold exercise; urgent surgical/TAVR evaluation
Absolute Acute Pulmonary Embolism / DVT Thrombus propagation; acute cor pulmonale Withhold exercise until therapeutic anticoagulation ≥ 24 \ge 24 ≥ 24 –48h
Absolute Acute Myocarditis or Pericarditis Myocardial electrical instability; arrhythmias Strict exercise prohibition for 3 to 6 months
Relative Unbypassed Left Main Stenosis ≥ 50 % \ge 50\% ≥ 50% Extensive anterior wall ischemia Physician clearance; low-intensity monitored exercise
Relative Resting BP >200/110 mmHg Exertional intracranial hemorrhage / LV strain Rest 15 min; recheck; withhold if persistently elevated
Relative Mobitz II or 3rd-Degree AV Block Progression to ventricular asystole Withhold until permanent pacemaker implantation
Relative Hypertrophic Obstructive Cardiomyopathy Outflow tract gradient surge Individualized low-intensity; avoid Valsalva/hypovolemia
In-Session Exercise Termination Criteria
Exercise must be stopped immediately if any of the following physiological criteria occur:
Subjective Symptoms
Moderate-to-Severe Angina: Angina scale rating ≥ 2 \ge 2 ≥ 2 on a 1 to 4 scale (2 = moderate/bothersome, 3 = severe/intense, 4 = excruciating).
Excessive Dyspnea: Dyspnea scale rating ≥ 3 \ge 3 ≥ 3 on a 1 to 4 scale , or severe breathlessness disproportionate to workload.
Central Nervous System Symptoms: Dizziness, lightheadedness, ataxia, confusion, or impending syncope (cerebral hypoperfusion).
Signs of Hypoperfusion: Pallor, cold clammy diaphoresis, or peripheral cyanosis.
Patient Request: The patient's request to stop exercise must always be honored immediately.
Objective Hemodynamic & Electrocardiographic Criteria
Drop in Systolic Blood Pressure: Sustained drop in SBP of > 10 mmHg >10\text{ mmHg} > 10 mmHg below baseline , or a drop in SBP with increasing workload, particularly when accompanied by other ischemic signs (indicates acute left ventricular dysfunction or severe multivessel disease).
Excessive Hypertensive Response: Exertional SBP > 220 to 250 mmHg >220\text{ to }250\text{ mmHg} > 220 to 250 mmHg or DBP > 115 mmHg >115\text{ mmHg} > 115 mmHg .
ST-Segment Displacement: Horizontal or downsloping ST depression > 2.0 mm >2.0\text{ mm} > 2.0 mm ( 0.2 mV 0.2\text{ mV} 0.2 mV ) measured 80 ms past the J-point, or ST elevation > 1.0 mm >1.0\text{ mm} > 1.0 mm in non-infarction leads.
Complex Arrhythmias: Sustained or non-sustained ventricular tachycardia ( ≥ 3 \ge 3 ≥ 3 consecutive PVCs), multifocal PVCs, frequent paired PVCs, rapid supraventricular tachycardias, or onset of high-degree AV block (Mobitz II or complete heart block).
Acute Emergency Protocols & Nitroglycerin Safety
Cardiac rehabilitation facilities must maintain emergency crash carts with biphasic defibrillators, oxygen, ACLS medications, and established emergency algorithms.
Chest Pain Emergency Algorithm
Stop Exercise & Position Safely: Terminate exercise immediately. Assist the patient into a seated or semi-Fowler's position. Never leave the patient unattended.
Vital Signs & Diagnostic ECG: Obtain blood pressure, heart rate, pulse oximetry ( S p O 2 SpO_2 Sp O 2 ), and record an immediate 12-lead ECG to evaluate for ST-elevation MI or ischemic patterns.
Evidence-Based Oxygen Therapy: Administer supplemental oxygen (2 to 4 L/min via nasal cannula) only if hypoxemic ( S p O 2 < 90 % to 92 % SpO_2 < 90\%\text{ to }92\% Sp O 2 < 90% to 92% ) or in respiratory distress. Routine oxygen in normoxemic patients causes coronary vasoconstriction and increased oxidative injury.
Sublingual Nitroglycerin (SL NTG) Protocol:
Verify baseline SBP is ≥ 90 to 100 mmHg \ge 90\text{ to }100\text{ mmHg} ≥ 90 to 100 mmHg .
MANDATORY PDE-5 Inhibitor Screening: Question patient regarding recent use of phosphodiesterase type 5 inhibitors:
Sildenafil or Vardenafil: Withhold nitrates if taken within 24 hours .
Tadalafil: Withhold nitrates if taken within 48 hours (due to 17.5-hour half-life).
Combining nitrates with PDE-5 inhibitors causes massive cyclic GMP accumulation, severe refractory vasodilation, and fatal hypotension. Nitrates are also contraindicated in suspected right ventricular infarction or severe aortic stenosis due to acute preload failure.
Dosing: Administer one 0.4 mg SL NTG tablet or metered spray while seated. Recheck blood pressure, heart rate, and pain every 5 minutes. If pain persists and SBP remains ≥ 90 to 100 mmHg \ge 90\text{ to }100\text{ mmHg} ≥ 90 to 100 mmHg , repeat 0.4 mg every 5 minutes up to 3 total doses over 15 minutes .
Code Activation: If symptoms fail to resolve after the first dose in an outpatient setting, or if hemodynamic instability or STEMI develops, activate Code Blue or 911 immediately. Prepare the defibrillator, administer chewable aspirin (162 to 325 mg), and establish IV access.
Clinical Emergency Scenario: In-Session Exertional Ischemia
Clinical Scenario: A 63-year-old male with prior anterior MI is walking on the treadmill at 3.2 mph and 4% grade. At minute 14, he clutches his chest (Levine's sign) reporting 3/4 crushing retrosternal pressure. Telemetry shows 2.5 mm horizontal ST depression and frequent PVCs.
Protocol Execution:
Immediate Action: Stop treadmill immediately; assist patient to a seated armchair.
Initial Assessment: BP is 108/68 mmHg, HR 118 bpm, S p O 2 SpO_2 Sp O 2 95% on room air. Because S p O 2 ≥ 92 % SpO_2 \ge 92\% Sp O 2 ≥ 92% , oxygen is withheld.
Medication Screening: Staff confirms no PDE-5 inhibitor use in the past 48 hours. SBP is confirmed > 90 mmHg >90\text{ mmHg} > 90 mmHg .
Therapy: Administer 0.4 mg sublingual nitroglycerin tablet; order STAT 12-lead ECG.
Re-Check: At minute 5, chest pain decreases to 1/4, BP is 98/64 mmHg, and ST depression resolves to 0.5 mm. Staff contact the supervising physician, cancel exercise, and transfer the patient for urgent catheterization.